论文部分内容阅读
简介:本品为新型长效磺胺,是目前磺胺类药物中,在血中维持有效浓度时间最长的一种,其半衰期为150小时,每周仅需服药一次。本品除对细菌感染有效外,尚可与异烟肼合用治疗肺结核以增强其治疗效果,并对麻风有一定作用,对疟疾也有治疗和预防作用。国外称为Sulfadoxine,商品名为Fanasil或Fanazil,约于1963年应用于临床。国内于1967年开始试制,1969年应用于临床,1970年4月于上海鉴定。
Description: This product is a new long-acting sulfonamide, which is the longest sulfonamide drug in the blood to maintain the longest concentration of a half-life of 150 hours, only once a week medication. This product is effective in addition to bacterial infection, but also with the isoniazid combination treatment of tuberculosis in order to enhance its therapeutic effect, and has a certain effect on leprosy, but also for the treatment and prevention of malaria. Abroad known as Sulfadoxine, trade name Fanasil or Fanazil, about 1963 for clinical use. Domestic trials began in 1967, 1969 for clinical application, in April 1970 in Shanghai appraisal.